News

JDE Peet’s Milestones in Share Buyback Initiatives

JDE Peet’s Milestones in Share Buyback Initiatives

JDE Peet’s Highlights Recent Share Buyback Milestones

In a recent update, JDE Peet’s (EURONEXT: JDEP), the premier company in the coffee and tea sector, shared noteworthy progress regarding its share buyback program. The company successfully repurchased 24,108 shares between May 19, 2025, and May 23, 2025, underscoring its commitment to enhancing shareholder value.

Details of the Share Purchase

The shares were acquired at an average price of EUR 22.94 each, amounting to an overall expenditure of EUR 0.6 million. This repurchase is part of a more significant initiative, with the entire share buyback program allocated a robust budget of EUR 250 million, emphasizing the company's strategic focus on capital management and investor appeal.

Total Shares Repurchased

To date, JDE Peet’s has repurchased an impressive total of 3,646,770 ordinary shares, reflecting a comprehensive investment worth EUR 68.1 million. This significant endeavor not only illustrates the company's effective financial strategies but also its intention to return capital to shareholders, which is vital for maintaining shareholder trust and confidence.

The Strategic Importance of Share Buybacks

Share buybacks serve a dual purpose; they can improve earnings per share by reducing the total number of shares outstanding, and they often signal to the market that a company believes its shares are undervalued. For JDE Peet’s, this move aligns with the broader objective of enhancing shareholder returns and capitalizing on the company's strong market standing.

Regulatory Compliance and Transparency

This periodic update on the share buyback program is provided in accordance with the regulatory requirements specified in Article 2(3) of the EU Regulation 2016/1052. This regulation outlines the necessity for transparency in buyback transactions, ensuring that shareholders are well informed about the activities undertaken by the company to manage its equity.

Communications and Contacts

For media inquiries, Khaled Rabbani is available at +31 20 558 1735, and interested parties can reach out via email at Media@JDEPeets.com. Investors and analysts may contact Robin Jansen at +31 6 1594 4569 or through IR@JDEPeets.com. This open line of communication fosters trust and ensures that stakeholders have access to timely information about the company's financial health and strategic direction.

About JDE Peet’s

JDE Peet’s stands out as the leading pure-play coffee and tea company globally, serving around 4,400 cups of coffee or tea every second. The company has a diverse portfolio boasting over 50 brands, including well-known names such as L’OR, Peet’s, Jacobs, Senseo, and Tassimo, reaching markets in over 100 countries. In the prior year, JDE Peet’s reported sales totaling EUR 8.8 billion and employed a dedicated workforce of over 21,000. Their mission revolves around making every cup a memorable experience, emphasizing innovation and quality.

Frequently Asked Questions

What is the significance of JDE Peet's share buyback program?

The share buyback program reflects JDE Peet's commitment to enhancing shareholder value by reducing the number of shares outstanding, potentially increasing earnings per share.

How much has JDE Peet’s allocated for its share buyback program?

The total budget for JDE Peet's share buyback program is EUR 250 million.

What is the average price of the shares repurchased recently?

The average price for the shares repurchased between May 19 and May 23, 2025, was EUR 22.94 per share.

How can I contact JDE Peet’s for more information?

For media inquiries, you can reach Khaled Rabbani at +31 20 558 1735, and for investor relations, contact Robin Jansen at +31 6 1594 4569.

What are some brands owned by JDE Peet's?

JDE Peet's portfolio includes popular brands such as L’OR, Peet’s, Jacobs, Senseo, and Tassimo, among others, catering to diverse market needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 81

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 25

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 106

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 116

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 191

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading

Top 5 Most Recently Viewed Articles

Beijing's EV Export Rules Impact NIO and Li Auto Stocks

Updated Category News Views 298

Beijing Implements Stricter EV Export Regulations Affecting Stocks Recently, Chinese electric vehicle (EV) stocks NIO (NYSE: NIO) and Li Auto (NASDAQ: LI) have experienced a notable decline following announcements regarding new regulations by Beijing aimed at tightening the export of EVs. New Export Permit Requirements Effective from January 1, the Ministry of Commerce in...

Continue Reading
OceanaGold Set to Announce Q2 2025 Financial Results Soon

Updated Category News Views 122

Upcoming Financial Results from OceanaGold OceanaGold Corporation (TSX: OGC, OTCQX: OCAND) is gearing up to release its operational and financial results for the second quarter of 2025. This detailed announcement will take place after the market close, and it’s expected to shed light on the company's recent performance and highlight future prospects. Conference Call...

Continue Reading
India's July Industrial Growth Surpasses Expectations by 0.1%

Updated Category News Views 121

India's Industrial Output Shows Promising Growth in July Recent government data reveals that India's industrial output rose by a noteworthy 4.8% year-on-year in July. This figure has drawn attention since it slightly exceeds economists' forecast of 4.7% for the same month. These growing numbers reflect a resilient manufacturing sector that is steadily recovering....

Continue Reading
VideoAmp Extends Partnership with Paramount Global for Measurement

Updated Category News Views 180

VideoAmp and Paramount Global Strengthen Their Collaboration VideoAmp, a pioneering media measurement company, has recently announced the continuation of its long-term collaboration with Paramount Global. This partnership reflects a commitment to evolving the advertising landscape with precise audience insights. Comprehensive Audience Measurement This renewal provides...

Continue Reading
Empire State Realty Trust Delivers Strong Q3 Performance and Guidance

Updated Category News Views 53

Empire State Realty Trust Shows Remarkable Q3 Financial Results Empire State Realty Trust (NYSE: ESRT) demonstrated impressive financial outcomes in its most recent earnings call for the third quarter of 2024, surpassing analyst expectations significantly. The real estate investment trust revealed a Funds From Operations (FFO) totaling $69 million, translating to $0.26...

Continue Reading